Literature DB >> 32845306

Reply to Hasford and to Spinola et al.

Nir Eyal1,2,3, Marc Lipsitch4,5, Peter G Smith6.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32845306      PMCID： PMC7529012          DOI： 10.1093/infdis/jiaa458

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Response to Cioffi.

Authors:  Nir Eyal; Marc Lipsitch; Peter G Smith
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

2.  Why do we need some large, simple randomized trials?

Authors:  S Yusuf; R Collins; R Peto
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

3.  AIDS Activism and Coronavirus Vaccine Challenge Trials.

Authors:  Nir Eyal; Perry N Halkitis
Journal:  AIDS Behav       Date:  2020-12

4.  Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.

Authors:  Robert Steel; Lara Buchak; Nir Eyal
Journal:  J Med Ethics       Date:  2020-07-13       Impact factor: 2.903

5.  Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure.

Authors:  Nir Eyal; Marc Lipsitch; Peter G Smith
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

6.  Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.

Authors:  Nir Eyal
Journal:  Ethics Hum Res       Date:  2020-05-22

7.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

8.  Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.

Authors:  Joerg Hasford
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.